从高危患者下消化道分离出的念珠菌属对新型半合成棘白菌素LY303366及其他抗真菌药物的敏感性。
Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agents.
作者信息
Zhanel G G, Karlowsky J A, Zelenitsky S A, Turik M A, Hoban D J
机构信息
Department of Medical Microbiology, University of Manitoba, Canada
出版信息
Antimicrob Agents Chemother. 1998 Sep;42(9):2446-8. doi: 10.1128/AAC.42.9.2446.
Abstract
Fifty-two percent of stool specimens collected from 1,200 high-risk patients were colonized with yeasts, primarily Candida albicans (53. 6%) and Candida glabrata (35.7%). Susceptibilities to all antifungal agents tested, including LY303366, were similar to those reported previously for Candida species isolated from blood.
摘要
从1200名高危患者采集的粪便样本中，52%被酵母菌定植，主要是白色念珠菌（53.6%）和光滑念珠菌（35.7%）。对包括LY303366在内的所有测试抗真菌药物的敏感性，与先前报道的从血液中分离出的念珠菌属的敏感性相似。
相似文献
1
Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agents.从高危患者下消化道分离出的念珠菌属对新型半合成棘白菌素LY303366及其他抗真菌药物的敏感性。
Antimicrob Agents Chemother. 1998 Sep;42(9):2446-8. doi: 10.1128/AAC.42.9.2446.
2
In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents.临床酵母分离株对新型棘白菌素衍生物LY303366及其他抗真菌药物的体外敏感性
Antimicrob Agents Chemother. 1997 Apr;41(4):763-6. doi: 10.1128/AAC.41.4.763.
3
Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method.棘白菌素类药物阿尼芬净（VER002，LY-303366）对酵母病原体的抗真菌活性：采用M27-A微量稀释法的比较研究。
J Antimicrob Chemother. 2003 Jan;51(1):163-6. doi: 10.1093/jac/dkg018.
4
Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.念珠菌属对氟康唑耐药的临床分离株对棘白菌素LY303366、伊曲康唑和两性霉素B的敏感性。
J Antimicrob Chemother. 2000 Sep;46(3):475-7. doi: 10.1093/jac/46.3.475.
5
In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates.新型棘白菌素LY303366与两性霉素B和氟康唑相比对临床酵母分离株的体外活性。
Antimicrob Agents Chemother. 1997 May;41(5):1156-7. doi: 10.1128/AAC.41.5.1156.
6
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.新型棘白菌素MK-0991（L-743,872）与LY303366以及其他四种抗真菌药物针对念珠菌属血流分离株的活性比较
Diagn Microbiol Infect Dis. 1998 Sep;32(1):33-7. doi: 10.1016/s0732-8893(98)00050-9.
7
Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.棘白菌素LY303366、肺炎球菌素MK-0991和氟康唑对念珠菌属和新型隐球菌的体外活性比较。
Antimicrob Agents Chemother. 1997 Sep;41(9):1957-60. doi: 10.1128/AAC.41.9.1957.
8
In vitro kill curves of a new semisynthetic echinocandin, LY-303366, against fluconazole-sensitive and -resistant Candida species.新型半合成棘白菌素LY-303366对氟康唑敏感及耐药念珠菌属的体外杀菌曲线
Antimicrob Agents Chemother. 1997 Nov;41(11):2576-8. doi: 10.1128/AAC.41.11.2576.
9
Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans.半合成棘白菌素LY303366的光亲和类似物：白色念珠菌中棘白菌素靶点的鉴定
Antimicrob Agents Chemother. 1998 May;42(5):1187-94. doi: 10.1128/AAC.42.5.1187.
10
Evaluation of endpoints for antifungal susceptibility determinations with LY303366.使用LY303366进行抗真菌药敏测定终点的评估。
Antimicrob Agents Chemother. 1998 Jun;42(6):1387-91. doi: 10.1128/AAC.42.6.1387.
引用本文的文献
1
In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole.阿尼芬净对2500多株念珠菌临床分离株的体外活性，其中包括315株对氟康唑耐药的分离株。
J Clin Microbiol. 2005 Nov;43(11):5425-7. doi: 10.1128/JCM.43.11.5425-5427.2005.
2
Toxicity of LY303366, an echinocandin antifungal, in mice pretreated with glucocorticoids.棘白菌素类抗真菌药LY303366对用糖皮质激素预处理的小鼠的毒性
Antimicrob Agents Chemother. 2000 Feb;44(2):378-81. doi: 10.1128/AAC.44.2.378-381.2000.
本文引用的文献
1
Candidemia in a Canadian tertiary care hospital from 1976 to 1996.1976年至1996年加拿大一家三级护理医院的念珠菌血症。
Diagn Microbiol Infect Dis. 1997 Sep;29(1):5-9. doi: 10.1016/s0732-8893(97)00068-0.
2
In vitro activity of a new semisynthetic echinocandin, LY-303366, against systemic isolates of Candida species, Cryptococcus neoformans, Blastomyces dermatitidis, and Aspergillus species.新型半合成棘白菌素LY-303366对念珠菌属、新生隐球菌、皮炎芽生菌及曲霉属的全身感染分离株的体外活性
Antimicrob Agents Chemother. 1997 Apr;41(4):863-5. doi: 10.1128/AAC.41.4.863.
3
In vitro susceptibilities of clinical yeast isolates to a new echinocandin derivative, LY303366, and other antifungal agents.临床酵母分离株对新型棘白菌素衍生物LY303366及其他抗真菌药物的体外敏感性
Antimicrob Agents Chemother. 1997 Apr;41(4):763-6. doi: 10.1128/AAC.41.4.763.
4
Antifungal dynamics of LY 303366, an investigational echinocandin B analog, against Candida ssp.LY 303366（一种研究中的棘白菌素B类似物）对念珠菌属的抗真菌动力学
Diagn Microbiol Infect Dis. 1996 Nov-Dec;26(3-4):125-31. doi: 10.1016/s0732-8893(96)00202-7.
5
Mechanisms of association of Candida albicans with intestinal mucosa.白色念珠菌与肠黏膜的关联机制。
J Med Microbiol. 1987 Dec;24(4):333-41. doi: 10.1099/00222615-24-4-333.
Zotero 插件